Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | Neuropore |
Description | To discover novel therapeutics that will stop the progression of neurodegenerative diseases by Our Mission To discover novel therapeutics that will stop the progression of neurodegenerative diseases by targeting their underlying causes. Our Programs |
Keywords | Neuropore |
WebSite | neuropore.com |
Host IP | 66.180.64.225 |
Location | Canada |
Site | Rank |
US$4,893,439
Last updated: 2023-05-09 08:12:21
neuropore.com has Semrush global rank of 2,162,958. neuropore.com has an estimated worth of US$ 4,893,439, based on its estimated Ads revenue. neuropore.com receives approximately 564,628 unique visitors each day. Its web server is located in Canada, with IP address 66.180.64.225. According to SiteAdvisor, neuropore.com is safe to visit. |
Purchase/Sale Value | US$4,893,439 |
Daily Ads Revenue | US$4,518 |
Monthly Ads Revenue | US$135,511 |
Yearly Ads Revenue | US$1,626,128 |
Daily Unique Visitors | 37,642 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
neuropore.com. | A | 1799 | IP: 66.180.64.225 |
neuropore.com. | NS | 3600 | NS Record: ns43.domaincontrol.com. |
neuropore.com. | NS | 3600 | NS Record: ns44.domaincontrol.com. |
neuropore.com. | MX | 3600 | MX Record: 0 neuropore-com.mail.protection.outlook.com. |
neuropore.com. | TXT | 3600 | TXT Record: v=verifydomain MS=3506698 |
neuropore.com. | TXT | 3600 | TXT Record: MS=ms34421902 |
neuropore.com. | TXT | 3600 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
Our Mission To discover novel therapeutics that will stop the progression of neurodegenerative diseases by targeting their underlying causes. Our Programs CURRENT CLINICAL TRIALS UCB0599 Phase 2 in Patients with Early-stage PD News Neuropore Therapies, Inc., announced today that it received a $4.8M grant from The Michael J. Fox Foundation. Neuropore Therapies, Inc., announced today that it received a $4.8M grant from The Michael J. Fox Foundation (MJFF) for Parkinson’s Research to Support Development of Its TLR2 Program. See All News Events Neuropore Therapies will be present at BIO Asia International Conference 2020 March 10-11 2020 Tokyo, Japan See All Events NPT ® Publications Neuropore publishes paper describing preclinical in vivo characterization of small molecule targeting α-synuclein as a potential Parkinson’s disease therapeutic November 2nd, 2018 Report in Scientific Reports , describes the beneficial effects of NPT200-11 on multiple disease relevant endpoints in a |
HTTP/1.1 302 Found Date: Sun, 31 Oct 2021 12:57:27 GMT Server: Apache Location: https://www.neuropore.com/ Content-Type: text/html; charset=iso-8859-1 HTTP/1.1 200 OK Date: Sun, 31 Oct 2021 12:57:27 GMT Server: Apache Last-Modified: Thu, 12 Aug 2021 18:48:14 GMT Accept-Ranges: bytes Content-Length: 23733 Content-Type: text/html |
Domain Name: NEUROPORE.COM Registry Domain ID: 1510618175_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2018-01-21T16:29:43Z Creation Date: 2008-07-28T11:19:40Z Registry Expiry Date: 2027-07-28T11:19:40Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS43.DOMAINCONTROL.COM Name Server: NS44.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-18T22:51:47Z <<< |